The Lancet Pre-Submission Checklist: Global Health Readiness
The Lancet turns away a high proportion of submissions on in-house assessment alone. Verify these 10 items covering global health relevance, clinical significance, and what editors screen for first.
Readiness scan
Before you submit to The Lancet, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
The Lancet is the right target when the manuscript makes a practice-level or policy-level claim that matters across settings, not just inside one hospital system or one country.
Strong data alone is not enough if the abstract, cover letter, and first table do not make the global health consequence explicit.
This checklist is most useful when you want to test whether the paper already reads like a Lancet submission rather than hoping the editors will infer that importance for you.
Quick answer: The right Lancet pre-submission checklist tests whether the paper has both practice-level consequence and relevance beyond one local health system. The Lancet is not just screening for competent clinical research. It is screening for work that matters to an international medical readership and that can support a concrete change in understanding, practice, or policy. If that case is not visible immediately, the manuscript is unlikely to be a Lancet paper. For the broader cluster, see the Lancet journal overview.
Check your Lancet readiness in about two to three minutes with the free scan.
In Our Pre-Submission Review Work
Across Manusights submission reviews, Lancet drafts usually fail not because the medicine is weak but because the manuscript is still written as if the editor should infer the international consequence. Strong hospital-system data, a good national cohort, or a useful policy result can all still miss if the abstract and cover letter do not explain why the finding matters across settings.
That is the practical test this page is meant to impose. Before submission, the paper should already answer two questions cleanly: what changes because of this result, and why should a reader outside the originating system care now rather than later.
Global health relevance
1. Does the finding matter beyond one national context?
This is The Lancet's defining editorial test. The journal prioritises original research likely to change clinical practice or thinking about a disease, and it lists global public-health and health-policy research among its other areas of interest. A study conducted in one country must explain specifically how the findings apply to other health systems, populations, and resource settings.
A US-based trial with results relevant only to the US healthcare system may be better suited to JAMA. A UK-based study relevant only to the NHS may fit better at BMJ. The Lancet wants findings that travel across borders.
2. Does the paper address health equity or underserved populations?
The Lancet Group publishes a commitment to equity, diversity, and inclusion and asks authors to handle sex, gender, race, ethnicity, and disability data carefully. If your study has equity implications, make them explicit in the abstract and cover letter.
3. Are the implications for health policy visible?
The Lancet cares about policy impact alongside clinical practice. If the finding could inform health policy decisions, national treatment guidelines, or public health interventions, state this concretely. "This has policy implications" is vague. "This finding supports adding X to the national immunization schedule for countries with Y disease burden" is specific.
Clinical significance
4. Does the study change clinical practice at scale?
Not "could this eventually change practice" but "will clinicians manage patients differently after reading this?" The distinction matters. A mechanistic finding with therapeutic potential is not the same as evidence that changes treatment decisions now.
5. Is the study design appropriate for the clinical claims?
The Lancet favors large randomized trials, major cohort studies, and systematic reviews with clear clinical implications. Observational studies are published but face higher scrutiny. Post-hoc analyses are rarely accepted unless they reveal genuinely new clinical insights.
Reporting and compliance
6. Is the structured abstract complete and under 300 words?
The Lancet requires a structured summary of no more than 300 words. Research Articles should be up to 3,500 words for the main text (4,500 for randomised trials). The abstract must include the study's clinical and global health significance, not just the methods and results.
7. Is the appropriate reporting checklist complete?
CONSORT 2025 for trials, STROBE for observational, PRISMA for systematic reviews. The Lancet published the CONSORT 2025 statement simultaneously with Nature Medicine, BMJ, and JAMA. Compliance with the latest version is expected.
8. Is the clinical trial registered and documented?
Prospective registration before enrollment is required. The registration number must appear in the abstract. The full protocol, and a statistical analysis plan if there is one, should be submitted with the paper.
Cover letter and framing
9. Does the cover letter lead with the finding, not the introduction?
Editors read cover letters quickly. We recommend about 300 words or fewer (The Lancet sets no limit), with: 2 to 3 sentences on clinical or public health significance, 1 sentence on journal fit (why The Lancet specifically), and 1 sentence on compliance (registration, ethics, data availability).
Do not repeat the abstract. Do not explain your motivation for the study. State the finding and its significance.
10. Is the data sharing statement concrete?
The Lancet requires a data sharing statement. "Data available upon request" is increasingly insufficient. State specifically what data will be shared, when, through what mechanism, and under what conditions.
The readiness shortcut
Check your Lancet readiness automatically. The Manusights free scan evaluates your manuscript against The Lancet's editorial standards in about two to three minutes. You get a readiness score, desk-reject risk signal, and the top issues with direct quotes.
For papers targeting The Lancet, the The Lancet submission readiness check provides citation-integrity checks against scholarly metadata sources, figure-level feedback, and journal-specific calibration. For a paper where a Lancet rejection would set you back a full cycle, the Submission-Ready Dossier ($99) adds simulated reviewer objections on global relevance and study design, plus a ranked list of backup venues.
What gets Lancet papers desk rejected
- the clinical finding is strong but the global health relevance is not explicit
- the study is conducted in one country without explaining applicability elsewhere
- the finding confirms existing practice without changing it
- the study design cannot support the clinical claims
- the abstract buries the significance after the methods
- the cover letter is too long or too general
- the data sharing statement is vague
- the trial is not prospectively registered
For more detail, see How to Avoid Desk Rejection at The Lancet and The Lancet Submission Guide.
How The Lancet compares
Feature | The Lancet | NEJM | JAMA | BMJ |
|---|---|---|---|---|
Desk rejection | High (no published figure) | ~90% | ~85% | ~70% |
Acceptance rate | About 5% | <5% | 5 to 7% | ~7% |
Key requirement | Global health relevance + clinical impact | Practice-changing evidence | Clinical practice (US focus) | International clinical practice |
Health equity focus | Published EDI commitment and reporting guidance | Present but less central | Present | Present |
Word limit | 3,500 (4,500 for randomised trials) | 2,700 | Varies by type | Varies |
Cover letter | About 300 words or fewer recommended (no published limit); lead with finding | Required | Optional | Optional |
Submit If / Think Twice If
Submit if:
- the finding changes practice or policy in a way that travels beyond one institution or one country
- the study design is strong enough to support the level of claim in the abstract
- the cover letter can explain the international consequence in a few direct sentences
Think twice if:
- the paper is mainly a strong local-health-system story
- the clinical implication still depends on several speculative steps
- the manuscript is better suited to a specialty journal even if the data are excellent
When is this checklist most useful?
Use before submission if:
- This is your first submission to this journal
- The paper is career-critical
- You want to catch formatting and compliance issues before they trigger a desk return
Less critical if:
- You have a strong track record at this journal and know the editorial expectations
- Three experienced colleagues have already reviewed the manuscript
Readiness check
Run the scan while The Lancet's requirements are in front of you.
See how this manuscript scores against The Lancet's requirements before you submit.
Before you submit
A Lancet submission readiness check identifies the specific framing and scope issues that trigger desk rejection before you submit.
Frequently asked questions
The fastest check is whether the paper changes practice or policy beyond one local setting. A clinically strong result that does not travel beyond one health system is usually not a Lancet paper.
It should lead with the main finding and explain why the work matters to The Lancet's international medical readership. A long introduction to the topic is much less useful than a short statement of practice or policy consequence.
Trial registration, the correct study-specific checklist such as CONSORT or STROBE, and a concrete data-sharing statement are the main preventable blockers.
Skip it when the paper is clinically competent but only changes decisions inside one specialty or one national health system, or when the study design cannot support the practice-level claim.
Sources
Final step
Submitting to The Lancet?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Target journal The Lancet
Private API processing. Your manuscript is not used to train models.
See example reportsPut the guidance to work
Turn the guide into a complete submission package.
Use one final checklist, then verify the journal rule that controls the files, declarations, and reporting details you will submit.